Loading…

Novanta IncNOVTCompetitor analysis, valuation and peers

United States · USD·Information Technology›Electronic Equipment/Instruments

Maker of precision photonics, motion-control and vision components embedded inside medical and industrial equipment.

Momentum weak 26
Mkt cap
$4.46B
US dollars, full cap
Free float
99%
of shares outstanding
$/day
$72.9M
20-day average traded
Fwd P/E
29.4×
forward earnings
ROIC−WACC
-8.0 pp
WACC 12.3%
Hurdle
+22 pp
Req g minus delivered
Next earnings
104 days
2 Mar 2027
Close · USD$117.89
1D+2.2%
1W-4.4%
1M-13.1%
3M-19.0%
6M-23.2%
YTD-0.9%
1Y+14.6%
ATR %6.6%
Beta1.92
52w lowhigh33.2% off high

What Novanta does

Maker of precision photonics, motion-control and vision components embedded inside medical and industrial equipment.

Supplies components and subsystems that are designed into a customer's product for years, so a won design generates repeat orders for the life of that product line and sales track the customer's production. Medical equipment makers are a large share of buyers. It grew largely by acquiring small specialist technology firms.

Products and services

  • Laser/photonics components
  • Precision motion control
  • Machine vision components

Customers

  • Medical device OEMs
  • Industrial laser/automation equipment makers

Where it sits in the supply chain

  • Information Technology
  • Electronic equipment/instruments
  • Precision photonics & motion control

What could go right

  • Medical device/surgical robotics growth
  • Industrial laser automation demand

What could go wrong

  • Medical device capex cyclicality
  • Customer concentration risk

Moat: narrow (IP / patents, customer qualification, process know-how). Highly engineered components are designed into OEM medical/industrial products for years.

Headquarters: Bedford, Massachusetts, US · Founded: 2016 · Employees: 3,000

Named competitors

Novanta at a glance

Size Novanta (NOVT) is a United States Information Technology company (Electronic Equipment/Instruments) with a market value of $4.46B, the 1264th largest of 3,085 United States companies the cockpit tracks. Shares closed at $117.89 on 18 Nov 2026.

Performance Over six months the shares fell 23.2%, against -28.9% for the median peer and -2.2% for the United States market (cap-weighted) — 9th highest of 20 in its peer set.

Growth Revenue grew 13.2% over the last twelve months (peer median +4.6%); the operating margin is 11.8% (peer median 11.2%).

Valuation It trades at 29.4× forward earnings against a peer median of 23.7× (7th most expensive of 17).

Price implies For today's price to make sense, revenue must grow about 32% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +22 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 8.0 points below its cost of capital (12.3% WACC).

Short interest Short interest is 13.9% of the free float (30 Oct 2026).

Next results Next results expected around 2 Mar 2027 (exchange calendar; dates can move).

Relative performance

8010021 May 202621 Aug 202618 Nov 2026NOVT 76Peer median 71
Six months, rebased to 100: Novanta against the median of its 20 peers (local-currency closes).

Novanta financials

Reported figures in USD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue$1.09B$981M$949M$882M$861M
Revenue growth—+3%+8%+2%—
Gross profit$448M$408M$397M$382M$355M
EBITDA$202M$179M$180M$170M$161M
Net income$53.1M$53.8M$64.1M$72.9M$74.1M
Free cash flow$138M$48.4M$141M$89.6M$71.1M
Capital expenditure$23.9M$15.6M$17.2M$20.0M$19.6M
Total debt$894M$303M$471M$405M$489M

Quarterly statements and history in the cockpit →

Novanta competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-50%0%+50%-40%-20%0%+20%IFCNITRI00241468862700215260084868800900233577503406000547ONTVAIAS601567CGNX688785688001688167NOVT6-month return →1-month return →
Up and to the right = strong over both horizons. Novanta is the large dot.

Fundamentals: revenue growth against valuation

0%+50%0×100×200×IFCNITRI00241468862700215260084877503406CGNX688001688167NOVTRevenue growth (TTM) →Forward P/E →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Novanta is the large dot.

Capital: growth delivered against growth the price implies

0%+10%+20%+30%0%20%IFCNITRI00215260084868800900233577503406300763VAIAS601567CGNX688001NOVTGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Novanta is the large dot.

Novanta competitors and peer comparison

Head to head with its named competitors (NOVT vs COHR vs ROK vs IPGP)
CompanyMarket cap6M returnRevenue growthOp. marginForward P/EReq g
Novanta NOVT$4.46B-23%+13%12%29.4×32.4%
Coherent COHR$41.9B-41%+31%15%18.2×n/a
Rockwell Automation ROK$43.4B-9%+8%15%26.3×27.6%
IPG Photonics IPGP$2.80B-46%+15%5%32.4×25.5%
Cognex CGNX$8.27B-22%+16%25%25.5×23.5%
MKS MKSI$14.2B-32%+25%19%10.9×21.8%
Hamamatsu Photonics K.K 6965.T$3.91B-24%+15%11%28.1×17.8%
Teledyne Technologies TDY$28.9B+2%+8%20%23.2×16.2%

How Novanta compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Novanta against its 20 peers (data as of 18 Nov 2026)
MeasureNOVTPeer medianRank in peer set
1-month return-13.1%-9.2%9th lowest of 21
6-month return-23.2%-28.9%9th highest of 20
Distance from 52-week high-33.2%-47.1%7th highest of 21
Revenue growth (TTM)+13.2%+4.6%10th highest of 21
Operating margin11.8%11.2%11th highest of 21
Forward P/E29.4×23.7×7th most expensive of 17
Growth the price implies (Req g, 7 yrs)32.4%9.5%2nd most demanding of 14
Growth delivered (Del g)+10.7%+9.5%7th highest of 14
Hurdle (Req g minus delivered)+21.7 pp-2.4 pp2nd most demanding of 14
ROIC minus cost of capital-8.0 pp-0.8 pp7th lowest of 21
EV / EBITDA25.8×15.3×2nd most expensive of 7
Net debt / EBITDA3.7×-0.9×most indebted of 8

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginForward P/EReq gDelivered g
Novanta NOVTUnited States$4.46B-23%+13%12%29.4×32.4%+10.7%
INFICON IFCN.SWSwitzerland$4.54B-3%-2%17%32.9×20.9%+8.4%
Itron ITRIUnited States$4.30B+20%-4%14%14.5×9.5%+1.7%
CIQTEK 688828.SSChina$3.81Bn/a+33%-5%n/an/an/a
Wuhan Guide Infrared 002414.SZChina$6.24B-29%+89%29%36.1×n/an/a
Shenzhen SEICHI Technologies 688627.SSChina$3.12B-40%+65%3%94.6×n/an/a
GRG Banking Equipment 002152.SZChina$3.10B-26%0%9%21.9×3.0%+13.5%
Shanghai Lingang 600848.SSChina$2.84B-10%-26%15%18.4×12.6%+15.1%
China Railway Signal & Communication 688009.SSChina$7.30B+3%+1%12%14.8×-6.4%-2.9%
Kehua Data 002335.SZChina$2.64B-48%+5%5%29.5×15.5%+14.4%
Syntec Technology 7750.TWTaiwan$2.64B-48%+90%27%10.7×8.3%+24.3%
GeniuS Electronic Optical 3406.TWTaiwan$2.59B+36%+15%19%18.1×6.0%+9.5%
Addsino 000547.SZChina$2.54B-57%-6%-54%n/an/an/a
Oxford Nanopore Technologies ONT.LUnited Kingdom$2.54B+52%+15%-55%n/an/an/a
Ginlong Technologies 300763.SZChina$2.51B-55%+4%11%17.6×7.1%+27.2%
Vaisala VAIAS.HEFinland$2.46B+14%+2%16%27.0×9.7%+9.5%
Ningbo Sanxing Medical Electric 601567.SSChina$2.41B-36%-11%3%14.3×3.3%+15.1%
Cognex CGNXUnited States$8.27B-22%+16%25%25.5×23.5%+4.2%
Shenzhen CSL Vacuum Science & Technology 688785.SSChina$2.37B-47%-2%18%n/an/an/a
Suzhou HYC Technology 688001.SSChina$2.35B-42%+19%6%55.4×35.4%+5.9%
Focuslight Technologies 688167.SSChina$2.18B-68%+22%-9%227.2×n/an/a

Questions

Who are Novanta's main competitors?
Named competitors: Coherent Corp (COHR), Rockwell Automation (motion, adjacent) (ROK), IPG Photonics (IPGP), Cognex (CGNX), MKS (MKSI), Hamamatsu Photonics (6965.T). The cockpit's measured peer set (industry) also includes INFICON (IFCN.SW), Itron (ITRI), CIQTEK (688828.SS), Wuhan Guide Infrared (002414.SZ), Shenzhen SEICHI Technologies (688627.SS), GRG Banking Equipment (002152.SZ).
Is Novanta expensive compared with its peers?
On forward p/e it trades at 29.4× against a peer median of 23.7×, 7th most expensive of 17 in its peer set. For today's price to make sense, revenue must grow about 32% a year for seven years (Req g). Recent delivered growth is +11%, so the hurdle is +22 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Novanta stock performed?
Over six months to 18 Nov 2026 the shares returned -23.2% against -28.9% for the median peer; over one year +14.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.